InnoVen Capital (Temasek/Seviora)
InnoVen Capital is an Asia-wide venture-lending platform backed through Seviora, a Temasek subsidiary, and UOB. In India it operates across venture-backed companies from early growth through pre-IPO, combining medium-term loans with founder-friendly underwriting, follow-on capacity and an equity kicker where a borrower achieves a liquidity event.
At a glance
- Founded
- 2008
- Footprint
- Mumbai
- Stage
- Venture debt
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
InnoVen Capital (Temasek/Seviora) uses a venture debt approach across Venture debt, growth-stage technology, healthcare.
Current evidence
InnoVen’s India platform remains active under the Seviora/Temasek and UOB-backed Asia platform. The manager’s January 2026 Startup Outlook Report and current India site continue to describe venture debt from seed through pre-IPO, with more than $1B invested across 235+ Indian portfolio companies; its current India portfolio and team pages provide named borrowers and leadership. Fund-by-fund capacity, fees/carry and India-only returns remain not publicly disclosed.
Strategy
Venture debt
Sector focus
Venture debt, growth-stage technology, healthcare
Current signal
InnoVen’s India platform remains active under the Seviora/Temasek and UOB-backed Asia platform. The manager’s January 2026 Startup Outlook Report and current India site continue to describe venture debt from seed through pre-IPO, with more than $1B invested across 235+ Indian portfolio companies; its current India portfolio and team pages provide named borrowers and leadership. Fund-by-fund capacity, fees/carry and India-only returns remain not publicly disclosed.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.